ArticleCureus2024
Feasibility and Safety of Endovascular Aneurysm Repair (EVAR) in a District General Hospital: A Retrospective Study of 10-Year Outcomes.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular aneurysm repair (EVAR) represents a pivotal advancement in the treatment of abdominal aortic aneurysm (AAA).
objectiveThe primary objective of this study is to present a comprehensive overview of the EVAR service in a district-level vascular centre and to compare it with the national outcome to outline a service model for other district general hospitals.
methodPatients who underwent an EVAR procedure from 2015 over seven years were included. Retrospective data were collected from post-EVAR surveillance, and the National Vascular Registry (NVR) database was included.
resultA total of 99 patients were included. Most of the patients (96%) who underwent EVAR were over 65 years old at the time of the procedure and predominantly male, accounting for 90%. The 30-day post-EVAR mortality rate was low (0.9%). Most of the patients had no primary endoleaks (80%), which was almost comparable to the national standard (82.5%).
conclusionThis study showed the feasibility of successful implementation and safety of the EVAR program in a small district-level hospital. The outcome was comparable to the national standard. This study has identified the strengths and areas for improvement in the EVAR programme in such a setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.